AnalystsLiana MoussatosLiana Moussatos's Stock Forecasts
AnalystsLiana Moussatos
Sectors:
Analyst Ranking
Top 18%
#869 out of 4877 analysts
Average Return
+9.9%
Win Rate
45%26 out of 58
Risk vs Reward
Poor
Good
Liana Moussatos's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Verona Pharma PLCVRNA | +406.68% | $4.19 | $21.23 | 2022-06-16 - 2023-06-16 | Buy |
Verona Pharma PLCVRNA | +282.79% | $18.19 | $69.63 | 2024-02-29 - 2025-02-28 | Buy |
Xoma Royalty CorpXOMA | +142.21% | $57.80 | $140.00 | 2013-01-06 - 2014-01-07 | Buy |
Ascendis Pharma AASND | +127.52% | $28.27 | $64.32 | 2017-03-23 - 2018-03-23 | Buy |
Blueprint Medicines CorpBPMC | +75.57% | $58.50 | $102.71 | 2023-05-22 - 2024-05-22 | Buy |
Liana Moussatos Analyst Color
Get additional color on Liana Moussatos's coverage of popular stocks
Liana Moussatos's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Clearside Biomedical IncCLSD | 2 | Buy | $4.00 | N/A | Maintains | a year ago |
Verona Pharma PLCVRNA | 6 | Buy | $33.00 | N/A | Reiterates | a year ago |
United Therapeutics CorpUTHR | 6 | Buy | $308.00 | N/A | Reiterates | a year ago |
Blueprint Medicines CorpBPMC | 4 | Buy | $75.00 | N/A | Reiterates | 2 years ago |
Liquidia CorpLQDA | 3 | Sell | $3.00 | N/A | Downgrades | 3 years ago |
Ascendis Pharma AASND | 3 | Buy | $117.00 | N/A | Maintains | 3 years ago |
Pacira Biosciences IncPCRX | 4 | Buy | $94.00 | N/A | Maintains | 3 years ago |
Albireo Pharma IncALBO | 3 | Buy | $84.00 | N/A | Maintains | 4 years ago |
Xoma Royalty CorpXOMA | 4 | Hold | $22.00 | N/A | Downgrades | 4 years ago |
Jade Biosciences IncJBIO | 1 | Buy | $805.00 | N/A | Initiates Coverage On | 4 years ago |
Calcimedica IncCALC | 2 | Hold | $8.00 | N/A | Downgrades | 4 years ago |
Intercept Pharmaceuticals IncICPT | 4 | Buy | $88.00 | N/A | Maintains | 4 years ago |
Lexicon Pharmaceuticals IncLXRX | 2 | Hold | $8.00 | N/A | Downgrades | 4 years ago |
Astria Therapeutics IncATXS | 2 | Hold | $1.15 | N/A | Downgrades | 5 years ago |
Aimmune Therapeutics IncAIMT | 1 | Hold | $34.50 | N/A | Downgrades | 5 years ago |
Immunic IncIMUX | 1 | Buy | $59.00 | N/A | Initiates Coverage On | 5 years ago |
Axcella Health IncAXLA | 1 | Buy | $700.00 | N/A | Initiates Coverage On | 5 years ago |
Eiger Biopharmaceuticals IncEIGRQ | 1 | Buy | $990.00 | N/A | Maintains | 5 years ago |
Kala Bio IncKALA | 1 | Buy | $2,600.00 | N/A | Maintains | 5 years ago |
Biomarin Pharmaceutical IncBMRN | 4 | Buy | $164.00 | N/A | Maintains | 5 years ago |
Aquestive Therapeutics IncAQST | 3 | Buy | $36.00 | N/A | Maintains | 5 years ago |
Global Blood Therapeutics IncGBT | 2 | Buy | $95.00 | N/A | Maintains | 6 years ago |
Allena Pharmaceuticals IncALNAQ | 1 | Buy | $30.00 | N/A | Initiates Coverage On | 7 years ago |
Regulus Therapeutics IncRGLS | 4 | Buy | $720.00 | N/A | Reiterates | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.